EC
DRNA
EcoR1 Capital’s Dicerna Pharmaceuticals, Inc. DRNA Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q4 | – | Sell |
-1,249,812
| Closed | -$25.2M | – | 90 |
|
|
2021
Q3 | $25.2M | Buy |
+1,249,812
| New | +$25.2M | 0.88% | 21 |
|
|
2020
Q3 | – | Sell |
-2,721,993
| Closed | -$69.1M | – | 61 |
|
|
2020
Q2 | $69.1M | Sell |
2,721,993
-624,308
| -19% | -$15.9M | 5.11% | 7 |
|
|
2020
Q1 | $61.5M | Sell |
3,346,301
-281,296
| -8% | -$5.17M | 6.42% | 4 |
|
|
2019
Q4 | $79.9M | Sell |
3,627,597
-335,381
| -8% | -$7.39M | 7.2% | 3 |
|
|
2019
Q3 | $56.9M | Buy |
3,962,978
+646,571
| +19% | +$9.28M | 7.19% | 6 |
|
|
2019
Q2 | $52.2M | Hold |
3,316,407
| – | – | 5.28% | 8 |
|
|
2019
Q1 | $48.6M | Hold |
3,316,407
| – | – | 4.48% | 8 |
|
|
2018
Q4 | $35.5M | Sell |
3,316,407
-485,920
| -13% | -$5.19M | 3.55% | 10 |
|
|
2018
Q3 | $58M | Buy |
3,802,327
+841,180
| +28% | +$12.8M | 5.23% | 7 |
|
|
2018
Q2 | $36.3M | Sell |
2,961,147
-1,803,300
| -38% | -$22.1M | 3.45% | 8 |
|
|
2018
Q1 | $45.5M | Sell |
4,764,447
-72,100
| -1% | -$689K | 4.57% | 8 |
|
|
2017
Q4 | $43.7M | Buy |
4,836,547
+3,878,555
| +405% | +$35M | 4.92% | 6 |
|
|
2017
Q3 | $5.51M | Buy |
957,992
+190,000
| +25% | +$1.09M | 0.73% | 22 |
|
|
2017
Q2 | $2.44M | Buy |
767,992
+385,992
| +101% | +$1.22M | 0.43% | 22 |
|
|
2017
Q1 | $1.3M | Buy |
+382,000
| New | +$1.3M | 0.33% | 23 |
|